Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer

Figure 2

Depiction of BRCA mutations and PARP1 inhibitors blocking DNA repair and causing cell death [31]. Copyright ©  2009 Massachusetts Medical Society. All rights reserved.

(a)

(b)

(c)

(d)